









Markets
/
Stocks
/
nasdaq-rapp
/

Rapport Therapeutics Inc

RAPP

30.930USD

+0.310+1.01%

Close 12/24, 13:00（ET）Quotes delayed by 15 min

1.47BMarket Cap

LossP/E TTM



Rapport Therapeutics Inc

30.930

+0.310+1.01%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Rapport Therapeutics Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

-6.40%-17.46M

-53.31%-25.07M

-14.89%-20.24M

-39.48%-14.45M

-202.64%-16.41M

-147.80%-16.35M

-266.90%-17.61M

---10.36M

---5.42M

---6.60M

---4.80M

Net income from continuing operations

-53.53%-26.93M

-47.52%-26.73M

-6.15%-24.06M

-47.79%-19.98M

-101.37%-17.54M

-182.65%-18.12M

-268.78%-22.67M

---13.52M

---8.71M

---6.41M

---6.15M

Operating gains losses

16.89%256.00K

21.15%252.00K

60.53%244.00K

390.57%260.00K

852.17%219.00K

890.48%208.00K

913.33%152.00K

--53.00K

--23.00K

--21.00K

--15.00K

Other non-cash items

142.79%771.00K

158.36%391.00K

-100.38%-25.00K

319.08%725.00K

-1614.29%-1.80M

---670.00K

537.67%6.57M

--173.00K

--119.00K

--0.00

--1.03M

Change in working capital

875.26%3.70M

-2639.84%-3.37M

86.28%-433.00K

-31.02%1.34M

-120.88%-477.00K

89.34%-123.00K

-648.10%-3.16M

--1.94M

--2.28M

---1.15M

---422.00K

-Change in prepaid expenses

477.08%2.53M

-579.89%-4.32M

60.14%-825.00K

99.36%-12.00K

-232.28%-672.00K

173.95%900.00K

-241.58%-2.07M

---1.89M

--508.00K

---1.22M

---606.00K

-Change in other current assets

---362.00K

-2170.83%-497.00K

-288.89%-51.00K

127.83%32.00K

-100.00%0.00

4.35%24.00K

115.70%27.00K

---115.00K

--24.00K

--23.00K

---172.00K

Cash from non-recurring investing activities

Cash from operating activities

-6.40%-17.46M

-53.31%-25.07M

-14.89%-20.24M

-39.48%-14.45M

-202.64%-16.41M

-147.80%-16.35M

-266.90%-17.61M

---10.36M

---5.42M

---6.60M

---4.80M

Investing cash flow

Net cash from continuing investing activities

-4.29%134.00K

-97.72%22.00K

-72.85%291.00K

-84.27%226.00K

169.23%140.00K

1024.42%967.00K

1657.38%1.07M

--1.44M

--52.00K

--86.00K

--61.00K

Capital expenditures

-4.29%134.00K

-97.72%22.00K

-72.85%291.00K

-84.27%226.00K

169.23%140.00K

1024.42%967.00K

1657.38%1.07M

--1.44M

--52.00K

--86.00K

--61.00K

Net cash flow from disposal of fixed assets

-4.29%134.00K

-97.72%22.00K

-72.85%291.00K

-84.27%226.00K

169.23%140.00K

1024.42%967.00K

1657.38%1.07M

--1.44M

--52.00K

--86.00K

--61.00K

Net cash flow from investment products

-7.07%-56.64M

121.31%22.62M

152.19%21.32M

141.64%32.16M

---52.90M

---106.14M

---40.85M

---77.22M

----

--0.00

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-7.04%-56.78M

121.10%22.60M

150.16%21.03M

140.59%31.93M

-101901.92%-53.04M

-124439.53%-107.10M

-68631.15%-41.93M

---78.66M

---52.00K

---86.00K

---61.00K

Financing cash flow

Cash flow from continuous financing activities

19506.96%270.53M

-100.04%-63.00K

-99.99%5.00K

105.00%7.00K

-101.63%-1.39M

177158.89%159.35M

6.09%63.66M

---140.00K

--85.36M

---90.00K

--60.01M

Net cash flow from common stock issuance/repurchase

100.00%0.00

-100.00%0.00

---1.00K

100.00%0.00

-2681.48%-1.39M

530133.33%159.07M

-100.00%0.00

---6.00K

--54.00K

--30.00K

--24.00K

Net cash flow from preferred stock issuance/repurchase

----

-100.00%0.00

--0.00

-100.00%0.00

----

--63.94M

----

--85.31M

----

--0.00

Proceeds from stock option exercised by employees

--636.00K

--0.00

--6.00K

--7.00K

----

Net cash flow from other financing activities

--269.90M

-122.26%-63.00K

100.00%0.00

----

335.83%283.00K

-100.47%-283.00K

---134.00K

--0.00

---120.00K

--59.98M

Net cash from non-recurrent financing activities

Net cash from financing activities

19506.96%270.53M

-100.04%-63.00K

-99.99%5.00K

105.00%7.00K

-101.63%-1.39M

177158.89%159.35M

6.09%63.66M

---140.00K

--85.36M

---90.00K

--60.01M

Net cash flow

Beginning cash balance

-49.97%55.17M

-22.40%57.71M

-18.99%56.91M

-75.27%39.42M

38.65%110.27M

-13.82%74.37M

125.47%70.25M

--159.41M

--79.53M

--86.30M

--31.16M

Current period cash flow changes

377.05%196.29M

-107.07%-2.54M

-80.60%799.00K

119.62%17.49M

-188.69%-70.85M

629.85%35.90M

-92.53%4.12M

---89.16M

--79.88M

---6.78M

--55.14M

Ending cash balance

537.93%251.46M

-49.97%55.17M

-22.40%57.71M

-18.99%56.91M

-75.27%39.42M

38.65%110.27M

-13.82%74.37M

--70.25M

--159.41M

--79.53M

--86.30M

Free cash flow

-6.31%-17.60M

-44.88%-25.09M

-9.85%-20.53M

-24.40%-14.67M

-202.32%-16.55M

-159.07%-17.32M

-284.35%-18.69M

---11.79M

---5.48M

---6.69M

---4.86M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

